| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |